Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - OPERATING INCOME
Operating Income TVTX - Travere Therapeutics, Inc.
-321 M
LAST VALUE
-12.90%
2 YEAR CAGR
-26.29%
5 YEAR CAGR
-14.92%
10 YEAR CAGR